Results of the Medical Research Council (MRC) Myeloma IX study: Effects of zoledronic acid (ZOL) on overall survival (OS) in patients with multiple myeloma (MM)

Autor: Morgan*, G.J., Davies, F.E., Gregory, W.M., Bell, S.E., Szubert, A.J., Navarro Coy, N., Ashcroft, A.J., Drayson, M.T., Owen, R.G., Jackson, G.H., Child, J.A.
Zdroj: In Bone 2011 48(1):S16-S17
Databáze: ScienceDirect
Externí odkaz: